You can Subscribe to our RSS FEED: which delivers brain tumor news and additions to the website via RSS.
Click HERE for details on RSS.
Displaying items 4601 to 4625 of about 5880
Next 25
10/26/2005
New approach to chemo: Continuous, lower doses
FDA Approves Brain Stem Cell Transplant and Genentech Inks Another Brain Cancer Deal
Oncolytics Biotech Inc. Announces 2005 Third Quarter Results
Three new genetic mutations in brain tumors identified
Exploring Avastin`s effects on brain cancer
10/25/2005
BRAIN TUMOUR AWARENESS - INTERNATIONAL LOGO COMPETITION KICKS OFF IN PARIS
10/23/2005
The Efficacy of Postoperative Ondansetron (Zofran®) Orally Disintegrating Tablets for Preventing Nausea and Vomiting After Acoustic Neuroma Surgery
10/20/2005
$10M grant aids cancer research
Nanoparticles to target and treat brain tumors
Celldex Announces Acquisition of Lorantis Limited and Assets of Alteris Therapeutics, Inc. (Note: Mentions brain tumor vaccine)
Genentech in collaboration to explore Avastin for brain cancer treatment
Light Sciences snags $35M in early stock offering
10/19/2005
virtualtrials.com will be out of service tonight
Brain cancer patients fight an unseen enemy Advice and updated information offered at recent area conference
November 13th Brain Tumor Awareness Day: PurpleTrunk, The Brain Tumor Foundation and David Craig Welch Form an Alliance to Focus on Education, Early Detection and Fund Raising
Oncolytics Biotech Inc. Ends Patient Treatment in Canadian Phase I Recurrent Malignant Glioma Clinical Trial
NeoPharm Investigators Present Preliminary Phase I Data of Cintredekin Besudotox in the Treatment of Malignant Glioma at Initial Diagnosis
10/18/2005
Autumn Birth Linked to Childhood Brain Cancer
O6–BG May Help Re-Sensitize Cancer Cells to Temodar® in Brain Cancer
10/14/2005
Support Group for Parents of children with brain tumors (NY)
The Guardian Brain Foundation 3rd annual Butterfly Ball
10/06/2005
Attacking Brain Cancer At Tumor Site Extends Survival
10/05/2005
NEOPHARM ANNOUNCES CINTREDEKIN BESUDOTOX POSTER PRESENTATION AT 55TH ANNUAL MEETING OF THE CONGRESS OF NEUROLOGICAL SURGEONS
The National Brain Tumor Foundation and the Brain Tumor Society are teaming up to provide a web conference on rehabilitation for brain tumor patients.
Phase I trial of temozolomide plus o6-benzylguanine for patients with recurrent or progressive malignant glioma.